Negara: Inggris
Bahasa: Inggris
Sumber: VMD (Veterinary Medicines Directorate)
Butorphanol
VMD NV
QN02AF01
Butorphanol
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cats, Dogs, Horses
Neurological Agent analgesic
Authorized
2009-09-02
Revised: October 2020 AN: 00793/2020 Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Alvegesic vet. 10 mg/ml Solution for injection for Horses, Dogs and Cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution for injection contains: Active substance: Butorphanol 10.00 mg (equivalent to Butorphanol tartrate 14.58 mg) Excipients: Benzethonium chloride 0.10 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection Clear, colourless solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horse, Dog, Cat. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES HORSE As an analgesic: For relief of moderate to severe abdominal pain (alleviates abdominal pain associated with colic of gastrointestinal origin). As a sedative: For sedation after the administration of certain alpha2-adrenoceptor agonists (detomidine, romifidine). DOG As an analgesic: For relief of moderate visceral pain. As a sedative: For sedation in combination with certain alpha2-adrenoceptor agonists (medetomidine). As a pre-anaesthetic: For pre-anaesthesia as sole agent and in combination with acepromazine. As an anaesthetic: For anaesthesia in combination with medetomidine and ketamine. CAT As an analgesic for the relief of moderate pain: For pre-operative analgesia in combination with acepromazine/ketamine or xylazine/ketamine. For post- operative analgesia after small surgical procedures. As a sedative: For sedation in combination with certain alpha2-adrenoceptor agonists (medetomidine). As an anaesthetic: For anaesthesia in combination with medetomidine and ketamine. Revised: October 2020 AN: 00793/2020 Page 2 of 11 4.3 CONTRAINDICATIONS Do not use in case of known hypersensitivity to the active substance or to any of the excipients. Do not use in animals with severe dysfunction of the liver or kidneys. Use of butorphanol is contraindicated in case of cerebral injury or organic brain lesions and in animals with obstructive respiratory disease, heart dysfunction or Baca dokumen lengkapnya